127 related articles for article (PubMed ID: 38170549)
21. Disparities in ovarian cancer treatment and overall survival according to race: An update.
Huffman DL; Jayakrishnan TT; Shankar K; Peterson CE; Wegner RE
Gynecol Oncol; 2021 Sep; 162(3):674-678. PubMed ID: 34261593
[TBL] [Abstract][Full Text] [Related]
22. The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.
Brewer KC; Peterson CE; Davis FG; Hoskins K; Pauls H; Joslin CE
Ann Epidemiol; 2015 Aug; 25(8):556-63. PubMed ID: 25986734
[TBL] [Abstract][Full Text] [Related]
23. Racial and socioeconomic disparities in adherence to preventive health services for ovarian cancer survivors.
Loomer L; Ward KC; Reynolds EA; von Esenwein SA; Lipscomb J
J Cancer Surviv; 2019 Aug; 13(4):512-522. PubMed ID: 31172430
[TBL] [Abstract][Full Text] [Related]
24. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
25. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
[TBL] [Abstract][Full Text] [Related]
26. Global ovarian cancer health disparities.
Chornokur G; Amankwah EK; Schildkraut JM; Phelan CM
Gynecol Oncol; 2013 Apr; 129(1):258-64. PubMed ID: 23266352
[TBL] [Abstract][Full Text] [Related]
27. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
Rojas C; Tian C; Powell MA; Chan JK; Bateman NW; Conrads TP; Rocconi RP; Jones NL; Shriver CD; Hamilton CA; Maxwell GL; Casablanca Y; Darcy KM
Gynecol Oncol; 2020 Apr; 157(1):67-77. PubMed ID: 32029291
[TBL] [Abstract][Full Text] [Related]
28. Social determinants of Black-White disparities in breast cancer mortality: a review.
Gerend MA; Pai M
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):2913-23. PubMed ID: 18990731
[TBL] [Abstract][Full Text] [Related]
29. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
Terplan M; Schluterman N; McNamara EJ; Tracy JK; Temkin SM
Gynecol Oncol; 2012 Apr; 125(1):19-24. PubMed ID: 22108636
[TBL] [Abstract][Full Text] [Related]
30. Disparities in treatment and survival among elderly ovarian cancer patients.
Taylor JS; He W; Harrison R; Zhao H; Sun CC; Lu KH; Giordano SH; Meyer LA
Gynecol Oncol; 2018 Nov; 151(2):269-274. PubMed ID: 30253875
[TBL] [Abstract][Full Text] [Related]
31. Disparities in clinical trial participation in ovarian cancer: A real-world analysis.
Smith AJB; Alvarez R; Heintz J; Simpkins F; Ko EM
Gynecol Oncol; 2023 Aug; 175():25-31. PubMed ID: 37300995
[TBL] [Abstract][Full Text] [Related]
32. Racial/ethnic disparities in ovarian cancer research.
Peres LC; Schildkraut JM
Adv Cancer Res; 2020; 146():1-21. PubMed ID: 32241384
[TBL] [Abstract][Full Text] [Related]
33. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.
Collins Y; Holcomb K; Chapman-Davis E; Khabele D; Farley JH
Gynecol Oncol; 2014 May; 133(2):353-61. PubMed ID: 24406291
[TBL] [Abstract][Full Text] [Related]
34. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
Karia PS; Huang Y; Tehranifar P; Visvanathan K; Wright JD; Genkinger JM
Am J Obstet Gynecol; 2022 Aug; 227(2):257.e1-257.e22. PubMed ID: 35489439
[TBL] [Abstract][Full Text] [Related]
35. Racial survival disparities in head and neck cancer clinical trials.
Liu JC; Egleston BL; Blackman E; Ragin C
J Natl Cancer Inst; 2023 Mar; 115(3):288-294. PubMed ID: 36477855
[TBL] [Abstract][Full Text] [Related]
36. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM
J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237
[TBL] [Abstract][Full Text] [Related]
37. Gaining a deeper understanding of social determinants of preterm birth by integrating multi-omics data.
Hong X; Bartell TR; Wang X
Pediatr Res; 2021 Jan; 89(2):336-343. PubMed ID: 33188285
[TBL] [Abstract][Full Text] [Related]
38. Impact of quality of care on racial disparities in survival for endometrial cancer.
Huang AB; Huang Y; Hur C; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2020 Sep; 223(3):396.e1-396.e13. PubMed ID: 32109459
[TBL] [Abstract][Full Text] [Related]
39. Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?
Ross J; Braswell KV; Madeira da Silva L; Mujica F; Stutsman S; Finan MA; Nicolson W; Harmon MD; Missanelli M; Cohen A; Singh A; Scalici JM; Rocconi RP
Gynecol Oncol; 2017 May; 145(2):329-333. PubMed ID: 28215839
[TBL] [Abstract][Full Text] [Related]
40. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]